Press Releases

A serious difficulty when working with fragile pharmaceuticals is delivering the formulation to the patient in a safe and effective manner. Thankfully, industryleading experts such as…
Read More...

SMi Reports: Key sessions confirmed for SMi’s 4th Annual 3D Cell Culture 2020 in London SMi’s 4th Annual 3D Cell Culture will commence on the 19th and 20th February 2020, in London.…
Read More...

SMi Reports: Leading industry expert from AstraZeneca to present at Pre-Filled Syringes and Injectable Drug Devices conference 2020, this January. SMi’s 12th annual Pre-Filled…
Read More...

SMi Reports: The morning session on day two of SMi’s RNA Therapeutics conference will pay a particular focus to “Downregulating Therapeutic Technologies”. SMi are proud to host the…
Read More...

Last week marked an exciting time for the RAS community with Boehringer Ingelheim advancing the first Pan-KRAS inhibitor into clinical testing. Don’t miss this unique opportunity to…
Read More...

SMi Reports: the agenda and speaker overview of the upcoming SMi’s 22nd Annual Superbugs & Superdrugs Conference 2020, in London is now available to view. SMi Group is delighted…
Read More...

SMi has released an exclusive interview with industry expert John Lisman, Attorney, Consultant and Trainer of Lisman Legal Life sciences B.V., ahead of the upcoming Parallel Trade…
Read More...

SMi has released an exclusive interview with industry expert Torsten Kneuss, Quality Assurance Manager Combination Products of Bayer, ahead of the upcoming Pre-Filled Syringes and…
Read More...

During the 2019 edition of the PREDiCT: 3D Tissue Models Summit, we caught up with StemoniX ahead of their presentation to gain insight on their current work and future projects!…
Read More...

SMi has released an exclusive interview with industry expert Che Connon, Professor of Tissue Engineering at Newcastle University, ahead of the upcoming Ophthalmic Drugs conference which…
Read More...

SMi Reports: A Focus Day has been added to SMi’s RNA Therapeutics Conference, which will highlight the recent developments in "Oligonucleotide Delivery Systems." SMi Group are proud to…
Read More...

SMi Reports: Registration is open for SMi’s inaugural AI in Drug Discovery conference taking place in London in March 2020. SMi is delighted to announce the highly anticipated AI in…
Read More...

SMi has released an exclusive interview with industry expert Richard Marsden, CEO of Synairgen, ahead of the upcoming Respiratory Drug Delivery conference this December. Respiratory…
Read More...

Shifting the paradigm from targeting protein to targeting RNA requires rethinking several aspects of drug discovery including target selection, lead discovery, assays to support lead…
Read More...

Panel Discussion: Targeting RNA with Small Molecules to Capture the Therapeutic Opportunities At this year’s 2nd RNA-Targeted Drug Discovery Summit (December 2-4, Boston), an expert…
Read More...

The recent expansion of the RNA space has resulted in the emergence of many specialised biotechs, particularly in North America and Europe. Investment ranges from $30-70mil across the…
Read More...

SMi Reports: Karl Hess from OnDigitalHealth Consulting to present at Disruptive Technologies in Pharma conference in London on the 20th and 21st January SMi is delighted to present…
Read More...

SMi Reports: Exclusive interview with Cedric Gysel from Johnson and Johnson ahead of the 12th annual Pre-Filled Syringe and Injectable Drug Devices conference being held in London on…
Read More...

SMi Reports: Overview of the workshops for Europe’s only Parallel Trade conference and exhibition taking place in February 2020 in London. SMi’s highly anticipated Parallel Trade…
Read More...

Boston – October 18, 2020 Continuous process first gained pharma and biotech’s attention in early 2010. It has taken Vertex and Janssen years before Symdeko and PREZISTA approved by…
Read More...